Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX0PKB
|
||||
| Drug Name |
SID24801614
|
||||
| Synonyms |
CHEMBL1896256
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C22H26N2O5
|
||||
| Canonical SMILES |
CC(C)C(NC(=O)C(Cc1ccccc1)NC(=O)OCc2ccccc2)C(=O)O
|
||||
| InChI |
InChI=1S/C22H26N2O5/c1-15(2)19(21(26)27)24-20(25)18(13-16-9-5-3-6-10-16)23-22(28)29-14-17-11-7-4-8-12-17/h3-12,15,18-19H,13-14H2,1-2H3,(H,23,28)(H,24,25)(H,26,27)
|
||||
| InChIKey |
AJQYZRHQCXCROF-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin L | Target Info | [1587926] | ||
| Cathepsin B | Target Info | [1587926] | |||
| Reactome | Endosomal/Vacuolar pathway | ||||
| Collagen degradation | |||||
| Degradation of the extracellular matrix | |||||
| Trafficking and processing of endosomal TLR | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentationR-HSA-1442490:Collagen degradation | |||||
| MHC class II antigen presentation | |||||
| WikiPathways | Primary Focal Segmental Glomerulosclerosis FSGS | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.